Kickstarting the Use of AI and Data Across the Biotech Industry

Artificial Intelligence has led to tremendous progress in areas such as image and speech recognition, but both adoption and impact in biotech and pharma has been lagging behind in relative terms. While fundamental reasons for this exist - such as a very different nature of the data available, and the different decisions that need to be supported in biotech/pharma, compared to ‘tech’ - there are also very practical and organisational barriers in place that need addressing. This article outlines some of those challenges, potential solutions, and makes a case for the HitchhikersAI.org grassroots movement that is aiming to improve upon the status-quo.